Sun Pharma completes acquisition of Antibe Therapeutics in CAD 4.5 million
TARO Pharmaceuticals Inc., a subsidiary of Sun Pharma, has completed 100 percent acquisition of Antibe Therapeutics Inc., Canada for a total consideration of CAD 4.5 million.
Antibe Therapeutics is an Ontario, Canada incorporated corporation based in Ontario, Canada. It is a clinical-stage biotechnological company developing novel drugs primarily focusing on reducing pain and inflammation.